A.J. Bouye

Cornerback

  • 2020 Salary Cap Charge: $13,437,500
  • % of 2020 Team Cap: 6.28%
  • 2020 Cash Payout: $13,500,000
  • % of 2020 Team Cash Spending: 7.34%
  • 2020 Cash to Cap Ratio: 1.00
  • Total Contract Value: $67,500,000
  • Annual Contract Value: $13,500,000
  • Position Ranking: 9/319 at CB
  • Fully Guaranteed Money: $26,000,000
  • Age: 29
  • Height: 6-0
  • Weight: 191
  • College: Central Florida
  • Accrued Seasons: 7
  • Entry: 2013 Undrafted Free Agent (Texans)
  • Year Signed: 2017 (UFA)
  • Free Agency: 2022 (UFA)
  • 2019 OTC Valuation: $3,723,000

Contract Notes

A.J. Bouye scheduled to be traded to the Denver Broncos on March 18, 2020.A.J. Bouye signed a five year, $67.5 million contract with the Jaguars on March 11, 2017.  Bouye's contract contains $26 million guaranteed. The guarantee package consists of a $10 million signing bonus and his 2017 and 2018 base salaries. The contract has yearly per game roster bonuses.

Current Contract

(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryPer Game Roster BonusCap
Number
Cap %
Dead Money & Cap Savings
202029$13,000,000$500,000$13,437,5006.3%
202130$13,000,000$500,000$13,500,0006.3%
Total$26,000,000$1,000,000$26,937,500
Career Earnings: $43,429,044
Career APY: $6,204,149
Potential Earnings: $70,429,044
Total Guarantees: $52,005,000
Largest Cash Payment: $13,500,000 (2017)
Largest Cap Number: $15,500,000 (2018)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
TexansUDFAExpired20133$1,490,000$496,667$5,000$1,414,29494.9%$471,431
TexansRFAExpired20161$1,671,000$1,671,000$0$1,671,000100.0%$1,671,000
JaguarsUFATraded20175$67,500,000$13,500,000$26,000,000$40,343,75059.8%$13,447,917
BroncosUFAActive20175$67,500,000$13,500,000$26,000,000$00.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Texans4$3,085,294$771,324$3,085,2940.0%$00.0%
Jaguars3$40,343,750$13,447,917$36,437,5000.0%$4,000,0000.0%
Broncos0$0$0$00.0%$00.0%

Salary Cap History

YearTeamBase SalaryProrated BonusPer Game Roster BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2013Texans$405,000$1,666$0$0$330,9600.3%$334,294
2014Texans$495,000$1,666$0$0$496,6660.4%$495,000
2015Texans$585,000$1,668$0$0$586,6680.4%$585,000
2016Texans$1,671,000$0$0$0$1,671,0001.1%$1,671,000
2017Jaguars$3,000,000$2,000,000$500,000$3,000,000$5,500,0002.7%$13,500,000
2018Jaguars$13,000,000$2,000,000$500,000$13,000,000$15,500,0007.3%$13,406,250
2019Jaguars$13,000,000$2,000,000$500,000$0$15,437,5007.7%$13,437,500
2020Broncos$13,000,000$0$500,000$0$13,437,5006.3%$13,500,000
2021Broncos$13,000,000$0$500,000$0$13,500,0006.3%$13,500,000
Total$58,156,000$6,005,000$2,500,000$16,000,000$66,460,294$70,429,044
Dead Money History
TeamYearCap ChargeCash Paid
Jaguars2020$4,000,000$0
Total$4,000,000$0

Statistics

YearGames PlayedGames MissedSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
201361000.3%14.1%2000000000000
2014142056.1%19.4%52700101031201101
2015151017.7%36.9%15100006290000
2016151071.4%20.1%4815162116100000
2017160097.4%13.6%5020000186700000
2018133080.8%10.0%46800008190000
2019142088.5%0.2%5015001081250000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$3,720,000$13,500,000
Injury Adjusted$4,605,188$11,812,500
test
OTC Valuation $2.5M $4.9M $7.4M $9.8M $12.3M APY $2.8M $5.6M $8.3M $11.1M $13.9M $3,695,000 $3,259,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.